CCM
ORIAW

Context Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Context Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,300
Closed -$3K – 616
2022
Q2 		$3K Sell
20,300
-860
-4% -$278 ﹤0.01% 591
2022
Q1 		$16K Buy
+21,160
New +$10.9K ﹤0.01% 608

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Context Capital Management's ORIAW Position: Q3 2022 in Review

Context Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q3 2022, closing a stake of 20,300 shares — an estimated $3K sold.

Context Capital Management first reported a position in ORIAW in Q1 2022 and held it in 2 quarters. The position peaked at $16K in Q1 2022. 31 funds tracked by Wall St. Rank hold ORIAW as of Q3 2022.

  • Context Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q3 2022 after selling out during the quarter.
  • Context Capital Management sold 20,300 Orion Biotech Opportunities Corp. Warrant shares in Q3 2022, an estimated $3K.
  • Context Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q1 2022 and held it in 2 quarters.
  • Context Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $16K in Q1 2022.
  • 31 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q3 2022.

Based on Context Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.